Literature DB >> 6167521

Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin.

I Florin, M Thelestam.   

Abstract

The cytopathogenic effect of partially purified toxin from Clostridium difficile on cultured human lung fibroblasts was studied. Conditions for determination of 50% tissue culture dose were standardized. The cytopathogenic effect of the toxin was dependent on toxin concentration, exposure time, and density of the cells. Transfer of the cells to 0 degrees C did not inhibit binding of toxin to the fibroblast surface, but prevented the development of the cytopathogenic effect. Both binding of toxin and some intracellular step(s) were prevented by 2,4-dinitrophenol. These preventative effects were reversible. Before and concomitantly with the appearance of the cytopathogenic effect, the cellular uptake of uridine and of amino acids was markedly stimulated. Protein synthesis was depressed when 100% of the cells showed the cytopathogenic effect, but the synthesis of nucleic acids was inhibited only several hours later. The primary cellular target for the toxin is still unknown.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167521      PMCID: PMC350654          DOI: 10.1128/iai.33.1.67-74.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Assay for early cytoplasmic effects of the src gene product of Rous sarcoma virus.

Authors:  D A McClain; P F Maness; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  Transmembrane interactions and the mechanism of capping of surface receptors by their specific ligands.

Authors:  L Y Bourguignon; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

4.  Cytochemical evaluation of metabolic inhibitors in cell culture.

Authors:  T Caspersson; S Farber; G E Foley; D Killander; A Zetterberg
Journal:  Exp Cell Res       Date:  1965-09       Impact factor: 3.905

5.  Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture.

Authors:  M Thelestam; M Brönnegård
Journal:  Scand J Infect Dis Suppl       Date:  1980

6.  Pseudomembranous colitis: Presence of clostridial toxin.

Authors:  H E Larson; A B Price
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

7.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

8.  Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

Authors:  G D Rifkin; F R Fekety; J Silva
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

9.  Action of cytochalasin D on cells of established lines. I. Early events.

Authors:  A F Miranda; G C Godman; A D Deitch; S W Tanenbaum
Journal:  J Cell Biol       Date:  1974-05       Impact factor: 10.539

10.  Action of cytochalasin D on cells of established lines. II. Cortex and microfilaments.

Authors:  A F Miranda; G C Godman; S W Tanenbaum
Journal:  J Cell Biol       Date:  1974-08       Impact factor: 10.539

View more
  14 in total

Review 1.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

2.  Identification of a novel virulence factor in Clostridium difficile that modulates toxin sensitivity of cultured epithelial cells.

Authors:  Masashi Miura; Haru Kato; Osamu Matsushita
Journal:  Infect Immun       Date:  2011-07-11       Impact factor: 3.441

3.  Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes.

Authors:  D C Dailey; A Kaiser; R H Schloemer
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

4.  Survey of the extrachromosomal gene pool of Clostridium difficile.

Authors:  L L Muldrow; E R Archibold; O L Nunez-Montiel; R J Sheehy
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

Review 5.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Clostridium difficile toxin A elicits Ca(2+)-independent cytotoxic effects in cultured normal rat intestinal crypt cells.

Authors:  C Fiorentini; G Donelli; P Nicotera; M Thelestam
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

7.  Effects of Clostridium difficile toxin B on human monocytes and macrophages: possible relationship with cytoskeletal rearrangement.

Authors:  J C Siffert; O Baldacini; J G Kuhry; D Wachsmann; S Benabdelmoumene; A Faradji; H Monteil; P Poindron
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

8.  Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.

Authors:  R Eglow; C Pothoulakis; S Itzkowitz; E J Israel; C J O'Keane; D Gong; N Gao; Y L Xu; W A Walker; J T LaMont
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile.

Authors:  S W Rothman; J E Brown; A Diecidue; D A Foret
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Loss of surface fibronectin from human lung fibroblasts exposed to cytotoxin from Clostridium difficile.

Authors:  T Ahlgren; I Florin; C Jarstrand; M Thelestam
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.